FiLLER Universal Treatments.
Cross-linked Hyaluronic acid 2.3 % (23 mg/mL).
Indicated for correction of medium to deep lines. Indicated for perioral wrinkles, lip contour and increase lip volume. It can be used for all areas of the face.
|10||4,00 €||Up to 40,00 €|
SAYPHA FILLER (1x1ml) / EX PRINCESS FILLER (1x1ml) CROMA
IN 2019 CROMA PRINCESS BECOMES CROMA SAYPHA
FILLER UNIVERSAL TREATMENTS
Based on hyaluronic acid (HA) of non-animal origin, thus hypoallergenic.
SAYPHA Filler is a monophasic, reticulated gel implant, based on hyaluronic acid of non-animal origin.
Cross-linked hyaluronic acid, formulated to a concentration of 23 mg/ml in a physiologic buffer.
CE Marked Medical Device class III. SMART - a unique method of cross–linking created by CROMA.
It is a universal product and appropriate for different aesthetic treatments such as the correction of moderate facial wrinkles and lines as well as the enhancement of lip volume.
Treatment is surprisingly simple and results are convincing – a natural, youthful, radiant appearance.
Cross-linked HA 2.3 % (23 mg/mL)
Level of cross-linking 2/4
Medium to deep derm.
That means no allergy testing is required previously to the treatment. The products are manufactured in Austria with a unique technology according to highest safety standards. The gels are absolutely pure, controlled and extremely well tolerated in the body. The treatment's results are immediately visible and long–lasting but not permanent.
2.3 % (23 mg/mL)
|Dynamic viscosity (at shear rate 2 s-1)||
70.000 – 100.000 mPa.s
2 x 27G 1⁄2 thin-wall needles
Box of 1 mL syringe
Mid to deep dermis
Viscoelastic solution for the correction of moderately deep facial wrinkles and to augment lip volume.
|Estimated duration in the skin||
Up to 9 months
SAYPHA® RICH (EC 0459)
regenerates the loss of hyaluronic acid due to aging, improves hydration, skin tone and elasticity and corrects fine lines. The product is injected into the superficial dermal layer.
SAYPHA® FILLER (CE 0459) and SAYPHA® FILLER Lidocaine (CE 0120)
corrects moderate to severe wrinkles and facial wrinkles and increases lip volume (only applicable for SAYPHA® FILLER Lidocaine). The product is injected into the intermediate to deep dermis.
SAYPHA® VOLUME (CE 0459) and SAYPHA® VOLUME Lidocaine (EC 0120)
have been developed to correct deeper wrinkles and wrinkles and to restore facial volume / reshape facial contours.
The product is injected into the deeper skin layer (deep dermis or hypodermis).
SAYPHA® VOLUME PLUS Lidocaine (EC 0120)
is used for facial tissue augmentation to correct lowering of the volume of the middle part of the face and to define the contours of the face as well as for reconstruction purposes, for example in the treatment of facial lipoatrophy.
The product is injected subcutaneously, locally or in the deep dermis. All products are made from non-animal hyaluronic acid and are manufactured to the highest standards of quality and safety.
Founded in 1976, Croma-Pharma GmbH (Croma) is an Austrian family-owned company specializing in the industrial production of hyaluronic acid for the fields of aesthetic medicine, ophthalmology and orthopedics. Croma currently manages 12 international sales companies and distributes its products in more than 70 countries. In its global sales network, Croma focuses on its own brand products for minimally invasive cosmetic medicine.
In addition to a wide range of hyaluronic acid-based fillers from its own production site, Croma markets PDO tensor yarns, a Platelet Rich Plasma System (PRP) and customized skin care technology. within its core strategic markets.